Market Cap 17.22M
Revenue (ttm) 28.94M
Net Income (ttm) -9.22M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -31.86%
Debt to Equity Ratio 0.56
Volume 16,500
Avg Vol 37,134
Day's Range N/A - N/A
Shares Out 4.26M
Stochastic %K 66%
Beta 1.26
Analysts Strong Sell
Price Target $26.00

Company Profile

BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 8 642 9100
Fax: 972 8 642 9101
Address:
Modi’in Technology Park, 2 HaMa’ayan Street, Hevel Modi'in, Israel
gargoyl
gargoyl Sep. 12 at 8:30 AM
$BLRX 👀 Longest the 🦋
0 · Reply
gargoyl
gargoyl Sep. 12 at 6:10 AM
0 · Reply
gargoyl
gargoyl Sep. 12 at 5:45 AM
$BLRX $BLUE Gamida Cell Arymid BlackRock PDAC SCD Aphreses Motixafortide APHEXDA Kreos Capital
0 · Reply
gargoyl
gargoyl Sep. 12 at 5:32 AM
$BLRX 🤔 👇
0 · Reply
gargoyl
gargoyl Sep. 12 at 5:17 AM
$BLRX 🗡️ $BLUE 🤔
1 · Reply
gargoyl
gargoyl Sep. 12 at 5:15 AM
$BLRX ⚔️ $BLUE
0 · Reply
gargoyl
gargoyl Sep. 12 at 5:12 AM
$BLRX ⚔️ $BLUE 🤔
0 · Reply
gargoyl
gargoyl Sep. 12 at 3:06 AM
$BLRX 👀 🤔 3 of 3 There is more than a foundation going on 👂 hear ..
0 · Reply
gargoyl
gargoyl Sep. 12 at 3:02 AM
$BLRX 👀 🤔 2 of 3 Is there a connection ??
0 · Reply
gargoyl
gargoyl Sep. 12 at 3:00 AM
$BLRX 👀 🤔 1 of 3 🦋 ‘ ‘ ‘ 🫴 ‘
0 · Reply
Latest News on BLRX
BioLineRx Ltd. (BLRX) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 10:44 AM EDT - 4 weeks ago

BioLineRx Ltd. (BLRX) Q2 2025 Earnings Call Transcript


Why Is Nano-Cap BioLineRx Stock Surging On Friday?

May 30, 2025, 1:58 PM EDT - 3 months ago

Why Is Nano-Cap BioLineRx Stock Surging On Friday?


BioLineRx Ltd. (BLRX) Q1 2025 Earnings Call Transcript

May 27, 2025, 12:55 PM EDT - 3 months ago

BioLineRx Ltd. (BLRX) Q1 2025 Earnings Call Transcript


BioLineRx to Report First Quarter 2025 Results on May 27, 2025

May 20, 2025, 7:00 AM EDT - 4 months ago

BioLineRx to Report First Quarter 2025 Results on May 27, 2025


BioLineRx Ltd. (BLRX) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 10:52 AM EDT - 5 months ago

BioLineRx Ltd. (BLRX) Q4 2024 Earnings Call Transcript


BioLineRx to Report 2024 Annual Results on March 31, 2025

Mar 24, 2025, 7:00 AM EDT - 6 months ago

BioLineRx to Report 2024 Annual Results on March 31, 2025


BioLineRx Issues Letter to Shareholders

Jan 21, 2025, 7:00 AM EST - 8 months ago

BioLineRx Issues Letter to Shareholders


Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet

Jan 6, 2025, 2:01 PM EST - 8 months ago

Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet


BioLineRx Announces $10 Million Registered Direct Offering

Jan 6, 2025, 8:57 AM EST - 8 months ago

BioLineRx Announces $10 Million Registered Direct Offering


BioLineRx Ltd. (BLRX) Q3 2024 Earnings Call Transcript

Nov 25, 2024, 10:58 AM EST - 10 months ago

BioLineRx Ltd. (BLRX) Q3 2024 Earnings Call Transcript


BioLineRx Ltd. (BLRX) Q2 2024 Earnings Call Transcript

Aug 15, 2024, 3:03 PM EDT - 1 year ago

BioLineRx Ltd. (BLRX) Q2 2024 Earnings Call Transcript


BioLineRx Ltd. (BLRX) Q1 2024 Earnings Call Transcript

May 28, 2024, 5:56 PM EDT - 1 year ago

BioLineRx Ltd. (BLRX) Q1 2024 Earnings Call Transcript


BioLineRx Announces $6 Million Registered Direct Offering

Apr 1, 2024, 9:00 AM EDT - 1 year ago

BioLineRx Announces $6 Million Registered Direct Offering


BioLineRx Ltd. (BLRX) Q4 2023 Earnings Call Transcript

Mar 26, 2024, 11:38 AM EDT - 1 year ago

BioLineRx Ltd. (BLRX) Q4 2023 Earnings Call Transcript


BioLineRx: Still A Buy, With Some Questions

Dec 4, 2023, 6:42 PM EST - 1 year ago

BioLineRx: Still A Buy, With Some Questions


BioLineRx Ltd. (BLRX) Q3 2023 Earnings Call Transcript

Nov 20, 2023, 1:54 PM EST - 1 year ago

BioLineRx Ltd. (BLRX) Q3 2023 Earnings Call Transcript


gargoyl
gargoyl Sep. 12 at 8:30 AM
$BLRX 👀 Longest the 🦋
0 · Reply
gargoyl
gargoyl Sep. 12 at 6:10 AM
0 · Reply
gargoyl
gargoyl Sep. 12 at 5:45 AM
$BLRX $BLUE Gamida Cell Arymid BlackRock PDAC SCD Aphreses Motixafortide APHEXDA Kreos Capital
0 · Reply
gargoyl
gargoyl Sep. 12 at 5:32 AM
$BLRX 🤔 👇
0 · Reply
gargoyl
gargoyl Sep. 12 at 5:17 AM
$BLRX 🗡️ $BLUE 🤔
1 · Reply
gargoyl
gargoyl Sep. 12 at 5:15 AM
$BLRX ⚔️ $BLUE
0 · Reply
gargoyl
gargoyl Sep. 12 at 5:12 AM
$BLRX ⚔️ $BLUE 🤔
0 · Reply
gargoyl
gargoyl Sep. 12 at 3:06 AM
$BLRX 👀 🤔 3 of 3 There is more than a foundation going on 👂 hear ..
0 · Reply
gargoyl
gargoyl Sep. 12 at 3:02 AM
$BLRX 👀 🤔 2 of 3 Is there a connection ??
0 · Reply
gargoyl
gargoyl Sep. 12 at 3:00 AM
$BLRX 👀 🤔 1 of 3 🦋 ‘ ‘ ‘ 🫴 ‘
0 · Reply
gargoyl
gargoyl Sep. 12 at 1:55 AM
$BLRX $VSTM Now Blrx @ $4 Vstm @ $9 The ying yang rub hear is thus SP relationship is ironically inverted to a juxtaposition of dyslexic symbiotic proportions, in the near future they will converge over and under $5 in the opposite direction.
0 · Reply
gargoyl
gargoyl Sep. 10 at 5:25 PM
0 · Reply
gargoyl
gargoyl Sep. 10 at 5:03 PM
$BLRX raise hand if smell $4 Longest the 🦋
0 · Reply
TwongStocks
TwongStocks Sep. 9 at 1:56 PM
$BLRX The Phase 1 study at St Jude's testing motixafortide as a stem cell mobilizer in patients with sickle cell has been updated. https://clinicaltrials.gov/study/NCT06442761 Big change to study completion dates. Primary completion was changed from Jan 2026 to Jan 2028. Study completion was changed from July 2026 to July 2028.
1 · Reply
gargoyl
gargoyl Sep. 8 at 3:20 PM
$BLRX time to average in.. losers cry , pray and hope …. Investors do DD and buy when all are running away.. PDAC , partnerships, Gloria , Arymid are foundations here .. revenues follow. Longest the 🦋
0 · Reply
DiaJay
DiaJay Sep. 4 at 11:52 PM
$BLRX “PERPETUAL DISAPPOINTMENT” Perpetual disappointment refers to a continuous state of feeling let down or dissatisfied due to unmet expectations or hopes.
0 · Reply
gargoyl
gargoyl Aug. 28 at 8:49 PM
$BLRX very questionable interesting noteworthy activity going on the bid side Level II … hmmm .02 And .09 Cents ..
0 · Reply
gargoyl
gargoyl Aug. 28 at 3:11 PM
$BLRX MM games, 7k volume , 7% commission spread on wide open book , giving a weak look, hmmmm , wonder why ?? Long the 🦋 we pop soon 🦍
1 · Reply
gargoyl
gargoyl Aug. 26 at 11:06 PM
$BLRX 👀 today’s market then snap back after hours smells like a pop tomorrow.. be on stand by .. Watching closely 🦍
0 · Reply
gargoyl
gargoyl Aug. 25 at 5:30 PM
$BLRX life is good, big sign Butterfly flies soon
0 · Reply
gargoyl
gargoyl Aug. 25 at 1:10 PM
$XBI with the 50 crossover 200 around $90 and higher lows from May 22 the chart looking for a continuation uptrend along side risk on Bio. This week, with a perfect storm all ships rise with incoming tide .. $BLRX 👀 for the $4.50 pop
0 · Reply
gargoyl
gargoyl Aug. 22 at 7:51 PM
$BLRX Just put aside some cold fresh brew coffee, something’s in life take time , hear 👂 is to the few longs 🫴🍷 , and to the looser short nay sayers 🤌 time to change sides .. have you noticed one of your leaders have already. Phil has cash, Phil has residual income revenue, Phil has PDAC, SCD, MM cards.. Not to mention 4 collaborations with respected Universities and entities , ie. St Jude.. Phil welcomes the haters as every brave investment that requires fortitude has the overnighters and miss informed untimely traders. One remedy, average in.
0 · Reply